Cervical cancer early recurrence rate

The probability of early recurrence of cervical cancer varies depending on factors such as treatment methods and tumor stages. The recurrence rate of early-stage patients within 5 years is usually very low. The risk of recurrence is mainly related to the persistence of pathological high-risk factors, incomplete treatment, and lack of standardized follow-up after surgery.

Patients with stage IA1-IB2 cervical cancer who receive standard surgery or radiotherapy have a very low risk of recurrence. For patients with localized lesions, the 5-year survival rate exceeds 90% after complete removal of the lesions and completion of adjuvant treatment. Recurrence is most common 12-24 months after surgery, and is mainly manifested as local recurrence in the pelvis, mostly caused by residual cancer cells at the surgical margin or incomplete removal of lymph node micrometastases. During follow-up, attention should be paid to symptoms such as abnormal vaginal discharge and contact bleeding. HPV testing and imaging evaluation should be reviewed every 3-6 months for two years after surgery.

The risk of recurrence increases when there are high-risk pathological factors such as lymphovascular space invasion or deep interstitial infiltration. Such patients still have a certain probability of recurrence even if they complete concurrent radiotherapy and chemotherapy. In addition, persistent HPV infection can lead to local immune function suppression and increase the risk of new lesions. About 60% of patients with recurrence are associated with distant metastasis. Common metastasis sites include the lungs, bones and liver. Patients with distant metastasis have a poor prognosis.

It is recommended to undergo regular gynecological examinations, tumor marker testing and imaging follow-up after completing treatment. Maintaining a healthy lifestyle can help reduce the risk of recurrence. Avoiding smoking, controlling chronic inflammation, and maintaining a reasonable weight within 5 years after surgery can improve the prognosis. If symptoms such as abnormal vaginal bleeding or pelvic pain occur, you should seek medical attention promptly for review.